To our study participants:

The safety of our staff, study participants, and community are of utmost importance to us. We also remain dedicated to continuing important research for our customers and will continue running our ongoing clinical trials. Our position of COVID-19 is influenced by the CDC, WHO, IRB, and local health authorities, and we have established the following precautions for our clinical trial activity:

-Weekly monitoring of threat levels in our area to determine if any new precautions need to be added.
-Increased cleaning and sanitation in our clinical trial units and throughout the building.
-Clinical trial participants and all staff advises that they should not come to site if they have symptoms of fever or cough, or if they have been around someone diagnosed.
-Participants coming in for screening and check-in will go directly to a designated triage room where they will have their temperature taken. If they are clear of fever or identified symptoms, they will proceed to their screening appointment. Anyone with a fever or symptoms will be separated and sent home.

We will continuously monitor the situation and will post any updates as needed.

Thank you.